# Evaluation of 3D Magnetic Resonance Spirometry: Comparison with Spirometry in Healthy Subjects and Patients with Respiratory Pathologies (asthma, COPD, Bilateral Lung Transplant)

> **NCT05724745** · NA · RECRUITING · sponsor: **Commissariat A L'energie Atomique** · enrollment: 240 (estimated)

## Conditions studied

- Asthma
- COPD
- BOS

## Interventions

- **DIAGNOSTIC_TEST:** 1. Standard spirometry
- **DIAGNOSTIC_TEST:** 2. 3D dynamic lung MRI at UTE in prone and supine positions
- **DRUG:** 3. Reversibility test with salbutamol
- **DIAGNOSTIC_TEST:** 4. 3D dynamic lung MRI at UTE in supine and prone position

## Key facts

- **NCT ID:** NCT05724745
- **Lead sponsor:** Commissariat A L'energie Atomique
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-26
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05724745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05724745, "Evaluation of 3D Magnetic Resonance Spirometry: Comparison with Spirometry in Healthy Subjects and Patients with Respiratory Pathologies (asthma, COPD, Bilateral Lung Transplant)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05724745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*